Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(15%)
Results Posted
60%(3 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
6
46%
Ph phase_3
2
15%
Ph phase_4
3
23%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(5)
Terminated(2)
Other(3)

Detailed Status

Completed5
unknown3
Recruiting2
Withdrawn1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (18.2%)
Phase 43 (27.3%)
N/A6 (54.5%)

Trials by Status

withdrawn18%
completed538%
unknown323%
enrolling_by_invitation18%
recruiting215%
terminated18%

Recent Activity

2 active trials
Showing 5 of 13
recruitingnot_applicable

EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment

NCT05790707
completedphase_4

CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial

NCT03716934
enrolling_by_invitationnot_applicable

The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.

NCT07077811
completednot_applicable

STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation

NCT03118518
recruiting

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

NCT06455488
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05790707Not Applicable

EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment

Recruiting
NCT03716934Phase 4

CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial

Completed
NCT07077811Not Applicable

The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.

Enrolling By Invitation
NCT03118518Not Applicable

STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation

Completed
NCT06455488

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

Recruiting
NCT04208997Phase 3

Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation

Terminated
NCT04863001

Use of Antiarrhythmic Drugs in Pediatrics

Unknown
NCT03734562Not Applicable

Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia

Completed
NCT02646501Not Applicable

Prospective Randomized Clinical Trial for Effect of Stellate Ganglion Block in Medically Refractory Ventricular Tachycardia

Unknown
NCT00116428Phase 3

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Completed
NCT01505296Phase 4

Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation

Withdrawn
NCT02051621Not Applicable

Therapy of Atrial Flutter by Afib Ablation

Unknown
NCT00863213Phase 4

Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13